Menu
NASP

All Activities

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

Attention Pharmacists and Pharmacy Techs: Click to access CPE Monitor and CE information More Information

Featured Activity

Learn about treatment options, treatment failure, associated adverse effects and more.

Find an Activity

Find an Activity

Find an Activity

Choose from the criteria below to find an activity that fits you best.

SHOW SEARCH

Oral Oncology - Clinical Module for Pharmacy Technicians, Part 2

To Participate

To participate in this continuing education activity:

  1. Review the activity description and objectives.
  2. View the activity.
  3. Complete the online post-test and activity evaluation.

This activity is available for free to members of NASP. Visit the top section of www.ProCE.com/CSPE for details.


 

A product of the National Association of Specialty Pharmacy's (NASP) Center for Specialty Pharmacy Education(CSPE). View more NASP/CSPE Activities
 

Activity Description

Pharmacy Technicians are key players in the healthcare team, and they play a vital role in the management of cancer patients. This module is for pharmacy technicians who are interested in exploring oncology, or those interested in expanding their knowledge of oncology patient management.

In this module, faculty will discuss treatment regimens for breast, prostate and lung cancers. After completing this module, the pharmacy technician will be able to recognize and identify different treatment categories used in cancer care and identify treatment specific genetic mutations that can assist them in pursuing insurance coverage for patients.

Learning Objectives

The target audience for this activity includes pharmacy technicians. Upon completion of this activity, participants will be able to:

  • List treatment regimens for breast cancer, prostate cancer, and lung cancer that may require a genetic mutation for usage.
  • Recognize and identify treatment specific genetic mutations necessary for medication prior authorization.
  • Describe nuances with insurance coverage of oral anti-cancer therapies and resources available to reduce financial toxicity.

Faculty

Reem Al Qazzaz, RPh
Banner Health

Wen Cheng, PharmD
HonorHealth

Jenny Pena, CPhT
Banner Health

Marie Sirek, PharmD, BCACP
Billings Clinic

Disclosure

It is the policy of ProCE, Inc. to ensure balance, independence, objectivity and scientific rigor in all of its continuing education activities. Faculty must disclose to participants the existence of any significant financial interest or any other relationship with the manufacturer of any commercial product(s) discussed in an educational presentation. None of the faculty have any relevant financial and/or commercial relationships to disclose.

CE Accreditation

Release Date: November 13, 2020
Expiration Date: November 13, 2023

Pharmacy Technicians

This CE activity is jointly provided by ProCE, Inc. and the National Association of Specialty Pharmacy (NASP). ProCE is accredited by the Accreditation Council for Pharmacy Education as a provider of continuing pharmacy education. ACPE Universal Activity Number 0221-9999-20-420-H01-T has been assigned to this knowledge-based, home-study activity. This CE activity is approved for 1.0 contact hour (0.1 CEU) in states that recognize ACPE providers. Completion of an evaluation and post-test with a score of 70% or higher is required to receive CE credit. Proof of completion will be posted in NABP CPE Monitor profiles. No partial credit will be given.

Funding

No external support has been received for this activity.

 

The material presented in this CE activity does not reflect the views of ProCE, LLC or the commercial sponsor. These materials may discuss uses and dosages for therapeutic products, processes, procedures and inferred diagnoses that have not been approved by the United States Food and Drug Administration. A qualified health care professional should be consulted before using any therapeutic product discussed. All readers and continuing education participants should verify all information and data before treating patients or employing any therapies described in this continuing education activity.